ReviewHypertension (Dallas, Tex. : 1979)2007
Is angiotensin II a direct mediator of left ventricular hypertrophy? Time for another look.
Review in Hypertension (Dallas, Tex. : 1979), 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
36 citing papers in PubMed.
- An integrated overview of acute heart failure: a narrative review of pathophysiological mechanisms and contributing factors.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2026Review
- Identification of immune-related genes and small-molecule drugs in hypertension-induced left ventricular hypertrophy based on machine learning algorithms and molecular docking.Frontiers in immunology · 2024Article
- Central role for BRAF in cardiac hypertrophy: rethinking the pathological-physiological divide.Clinical science (London, England : 1979) · 2023Article
- Oridonin Relieves Angiotensin II-Induced Cardiac Remodeling via Inhibiting GSDMD-Mediated Inflammation.Cardiovascular therapeutics · 2022Article
- Neurohormones, inflammatory mediators, and cardiovascular injury in the setting of heart failure.Heart failure reviews · 2020Review
- Telmisartan improves myocardial remodeling by inhibiting leptin autocrine activity and activating PPARγ.Experimental biology and medicine (Maywood, N.J.) · 2020Article
- The Mechanism of High-Output Cardiac Hypertrophy Arising From Potassium Channel Gain-of-Function in Cantú Syndrome.Function (Oxford, England) · 2020Article
- Chronic Kidney Disease as a Risk Factor for Heart Failure With Preserved Ejection Fraction: A Focus on Microcirculatory Factors and Therapeutic Targets.Frontiers in physiology · 2019Review
- Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.Physiological reviews · 2018Review
- The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.Pharmacological research · 2017Review
- Article
- Pathophysiology and clinical evaluation of acute heart failure.Nature reviews. Cardiology · 2016Review
- Clinical perspectives and fundamental aspects of local cardiovascular and renal Renin-Angiotensin systems.Frontiers in endocrinology · 2014Review
- Article
- Inactivation of the E-prostanoid 3 receptor attenuates the angiotensin II pressor response via decreasing arterial contractility.Arteriosclerosis, thrombosis, and vascular biology · 2012Article
- Intracardiac intracellular angiotensin system in diabetes.American journal of physiology. Regulatory, integrative and comparative physiology · 2012Review
- Aerobic exercise training-induced left ventricular hypertrophy involves regulatory MicroRNAs, decreased angiotensin-converting enzyme-angiotensin ii, and synergistic regulation of angiotensin-converting enzyme 2-angiotensin (1-7).Hypertension (Dallas, Tex. : 1979) · 2011Article
- New take on the role of angiotensin II in cardiac hypertrophy and fibrosis.Hypertension (Dallas, Tex. : 1979) · 2011Article
- Angiotensin II type 1A receptors in vascular smooth muscle cells do not influence aortic remodeling in hypertension.Hypertension (Dallas, Tex. : 1979) · 2011Article
- Local angiotensin II aggravates cardiac remodeling in hypertension.American journal of physiology. Heart and circulatory physiology · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.